Chancellor Rachel Reeves Aims for Focused Measures on Living Costs in Upcoming Budget
Treasury head Rachel Reeves has announced she is preparing "specific action to address household expense issues" in the upcoming financial statement.
Speaking to media outlets, she stated that lowering price rises is a joint responsibility of both the administration and the central bank.
The United Kingdom's inflation rate is projected to be the most elevated among the G7 developed nations this year and the following year.
Possible Energy Bill Measures
Sources suggest the government could take action to reduce energy bills, for instance by cutting the present 5% rate of VAT applied on energy.
Another option is to cut some of the regulatory levies currently included in household expenses.
Fiscal Constraints and Expert Expectations
The government will obtain the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for such measures.
The consensus from most economists is that the Chancellor will have to announce tax rises or budget cuts in order to meet her self-imposed fiscal targets.
Previously on the same day, estimates showed there was a twenty-two billion pound shortfall for the Treasury chief to fill, which is at the more modest range of forecasts.
"There's a joint job between the Bank of England and the government to bear down further on some of the sources of inflation," the Chancellor told the BBC in Washington, at the conferences of the International Monetary Fund and World Bank.
Tax Commitments and International Concerns
While a great deal of the focus has been on probable tax rises, the chancellor said the latest information from the fiscal watchdog had not altered her pledge to campaign commitments not to increase rates on earnings tax, sales tax or social security contributions.
She blamed an "unpredictable global environment" with increasing geopolitical and commercial tensions for the Budget revenue measures, likely to be targeted on those "most able to pay."
International Economic Tensions
Commenting on worries about the United Kingdom's trade ties with the Asian nation she said: "The UK's national security invariably come first."
Last week's declaration by China to strengthen export controls on critical minerals and other materials that are essential for high-technology manufacturing led American leader the US President to propose an additional 100% tariff on imports from China, raising the prospect of an all-out trade war between the two economic giants.
The US Treasury Secretary labeled China's decision "commercial pressure" and "a global supply chain control attempt."
Questioned on considering the American proposal to participate in its dispute with the Asian nation, Reeves said she was "deeply worried" by China's measures and called on the Beijing authorities "not to put up barriers and restrict access."
She said the move was "damaging for the international commerce and causes further headwinds."
"In my view there are fields where we need to challenge China, but there are also significant prospects to trade with China's economy, including financial services and other areas of the economy. We've got to get that equilibrium appropriate."
The chancellor also affirmed she was collaborating with G7 counterparts "regarding our own critical minerals strategy, so that we are less reliant."
NHS Drug Costs and Investment
Reeves also acknowledged that the cost the NHS spends on medicines could increase as a consequence of current discussions with the US government and its pharmaceutical firms, in return for lower tariffs and capital.
A number of the biggest global drug companies have said lately that they are either delaying or scrapping projects in the United Kingdom, with several attributing the insufficient payments they are getting.
Recently, the government science advisor said the price the NHS pays for drugs would need to go up to prevent firms and drug research funding leaving the UK.
The Chancellor informed media: "It has been observed because of the payment system, that medical research, recent pharmaceuticals have not been available in the UK in the way that they are in other European countries."
"The objective is to ensure that people getting treatment from the National Health Service are able to access the finest life-saving treatments in the globe. And so we are examining this situation, and... aiming to obtain increased funding into the UK."